Additionally, hemin treatment reduces the levels of oxidative stress markers in lung tissue and reduces the severity of ALI/ARDS in treated mice compared to untreated mice or mice treated with the HO-1 inhibitor zinc protoporphyrin IX (ZnPPIX) (Luo et al., 2014). This evidence concerns the gene HMOX1 and acute respiratory distress syndrome.